BR100 Increased By (0.93%)
BR30 Increased By (1.04%)
KSE100 Increased By (0.94%)
KSE30 Increased By (1.02%)
AGHA 6.37 Decreased By ▼ -0.01 (-0.16%)
BECO 4.36 Increased By ▲ 0.01 (0.23%)
BML 62.97 Increased By ▲ 0.42 (0.67%)
BOP 31.44 Increased By ▲ 0.05 (0.16%)
CNERGY 11.76 Increased By ▲ 0.03 (0.26%)
CSIL 5.76 Decreased By ▼ -0.15 (-2.54%)
FCCL 61.82 Increased By ▲ 0.11 (0.18%)
FFL 14.85 Increased By ▲ 0.06 (0.41%)
FNEL 1.29 Increased By ▲ 0.05 (4.03%)
KEL 6.34 Increased By ▲ 0.02 (0.32%)
KOSM 5.82 Decreased By ▼ -0.08 (-1.36%)
LOTCHEM 24.80 Increased By ▲ 0.11 (0.45%)
MLCF 106.35 Increased By ▲ 2.42 (2.33%)
NBP 174.45 Increased By ▲ 1.13 (0.65%)
NCPL 52.60 Increased By ▲ 0.77 (1.49%)
NPL 54.94 Increased By ▲ 0.91 (1.68%)
OGDC 318.90 Increased By ▲ 3.03 (0.96%)
PACE 9.30 Increased By ▲ 0.04 (0.43%)
PAEL 35.87 Increased By ▲ 0.29 (0.82%)
PIBTL 14.20 Increased By ▲ 0.54 (3.95%)
PPL 229.60 Increased By ▲ 3.53 (1.56%)
PRL 81.31 Increased By ▲ 1.03 (1.28%)
PTC 47.05 Increased By ▲ 0.41 (0.88%)
SSGC 24.07 Increased By ▲ 0.25 (1.05%)
TBL 9.40 Increased By ▲ 0.16 (1.73%)
TELE 7.63 Increased By ▲ 0.08 (1.06%)
TPL 24.65 Increased By ▲ 0.11 (0.45%)
TPLP 12.93 Decreased By ▼ -0.06 (-0.46%)
TREET 27.00 Increased By ▲ 1.02 (3.93%)
TRG 53.69 Increased By ▲ 0.36 (0.68%)
World

US secures 3.2mn doses of Novavax COVID vaccine

Published Updated
By

The US government has secured 3.2 million doses of COVID-19 vaccine developed by Novavax Inc , the Department of Health and Human Services (HHS) and the company said.

The vaccine has not yet been authorized for emergency use by the US Food and Drug Administration (FDA). Advisers to agency last month voted to recommend that the FDA authorize the shot for use in adults.

Australia seeks to expand fourth COVID dose eligibility amid fresh Omicron threat

Novavax is expected to complete all necessary quality testing in the next few weeks, which would support final release of the shots, HHS said.

Comments

Comments are closed for this article.